AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colles, S. L
Right arrow Articles by O'Brien, P. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colles, S. L
Right arrow Articles by O'Brien, P. E
Agricola
Right arrow Articles by Colles, S. L
Right arrow Articles by O'Brien, P. E
American Journal of Clinical Nutrition, Vol. 84, No. 2, 304-311, August 2006
© 2006 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging1,2,3

Susan L Colles, John B Dixon, Paul Marks, Boyd J Strauss and Paul E O'Brien

1 From the Centre for Obesity Research and Education (CORE), Monash University, Melbourne, Australia (SLC, JBD, and PEO); the Radiology Department, The Avenue Hospital, Windsor, Australia (PM); and the Department of Medicine, Monash University, Clayton, Australia (BJS)

Background: A very-low-energy diet (VLED) can result in substantial, rapid weight loss and is increasingly prescribed before obesity surgery to minimize risk and difficulty by reducing liver size and abdominal adiposity. Despite its growing popularity, a VLED in this setting has received little attention.

Objective: The aim of this study was to investigate the efficacy and acceptability of a preoperative VLED.

Design: In a prospective observational study, 32 subjects (n = 19 men and 13 women) with a mean (±SD) age of 47.5 ± 8.3 y and a body mass index (in kg/m2) of 47.3 ± 5.3 consumed a VLED for 12 wk. Primary outcomes included changes in liver volume (LV) and in visceral and subcutaneous adipose tissue (VAT/SAT). Changes in body weight, anthropometric measures, and biochemical variables were also recorded, and compliance with, acceptability of, and side effects of treatment were assessed. Changes in LV and VAT/SAT area were measured by computed tomography and magnetic resonance imaging at baseline and weeks 2, 4, 8, and 12.

Results: Mean (±SD) LV, VAT/SAT, and body weight decreased significantly (P < 0.001 for all). The degree of LV reduction was directly related to the reduction in relative body weight (r = 0.54, P = 0.001) and initial LV (r = 0.43, P = 0.015). Eighty percent of the reduction in LV occurred between weeks 0 and 2 (P < 0.001). Reductions in body weight and VAT were uniform over the 12-wk period. Attrition was 14%. Acceptability was adequate but waned over time, and mild transitory side effects occurred.

Conclusions: Given the observed early reduction in LV and the progressive reduction in VAT, we suggest that the minimum duration for a preoperative VLED be 2 wk. Ideally, the duration should be 6 wk to achieve maximal LV reduction and significant reductions in VAT and body weight without compromising compliance and acceptability.

Key Words: Severe obesity • fatty liver • very-low-energy diet • VLED • weight loss • surgery • laparoscopy • body composition




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kotronen and H. Yki-Jarvinen
Fatty Liver: A Novel Component of the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 27 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Kotronen, S. Vehkavaara, A. Seppala-Lindroos, R. Bergholm, and H. Yki-Jarvinen
Effect of liver fat on insulin clearance
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1709 - E1715.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
S. R. DiCecco
Medical Weight Loss Treatment Options in Obese Solid-Organ Transplant Candidates
Nutr Clin Pract, October 1, 2007; 22(5): 505 - 511.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition